SEC Form 3/A · accession 0001104659-18-063101
Osmotica Pharmaceuticals plc · OSMT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owners
Avista Capital Partners III GP, L.P.
10% Owner
Orbit Co-Invest I LLC
10% Owner
Orbit Co-Invest III LLC
10% Owner
ACP Holdco (Offshore), L.P.
10% Owner
ACP III AIV, L.P.
10% Owner
Period of report
Oct 18, 2018
Accepted (ET)
Oct 19, 2018 · 7:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | holding | — | — | — | 9,296,965 | I | By investment fund | |
| Ordinary SharesF1,F3 | holding | — | — | — | 5,183,899 | I | By investment fund | |
| Ordinary SharesF4 | holding | — | — | — | 4,936,926 | I | By investment fund | |
| Ordinary SharesF5 | holding | — | — | — | 1,032,995 | I | By investment fund |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment to the reporting persons' Form 3 filed on October 18, 2018 is being filed to correct the number of ordinary shares reported as beneficially owned in the original Form 3.
- F2Represents shares of the Issuer held by ACP III AIV, L.P. Avista Capital Partners III GP, L.P. ("ACP GP") is the general partner of ACP III AIV, L.P. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by ACP III AIV, L.P. Each of ACP III AIV, L.P. and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
- F3Represents shares of the Issuer held by ACP Holdco (Offshore), L.P. ACP GP is the general partner of ACP Holdco (Offshore), L.P. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by ACP Holdco (Offshore), L.P. Each of ACP Holdco (Offshore), L.P. and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
- F4Represents shares of the Issuer held by Orbit Co-Invest I LLC. ACP GP is the manager of Orbit Co-Invest I LLC. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest I LLC. Each of Orbit Co-Invest I LLC. and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
- F5Represents shares of the Issuer held by Orbit Co-Invest III LLC. ACP GP is the manager of Orbit Co-Invest III LLC. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest III LLC.. Each of Orbit Co-Invest III LLC and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.